Comorbidities and length of stay in chronic obstructive pulmonary disease patients

References

• Hess DR, MacIntyre NR, Galvin WF, Mishoe SC. Respiratory care: principles and practices. 3rd ed. Burlington (MA): Jones and Bartlett Publishing; 2016.
   Google Scholar
• Dalal AA. Direct costs of chronic obstructive pulmonary disease among managed care patients. Int J Chron Obstr Pulm Dis. 2010;5:341–349. doi:10.2147/COPD.513771.
   PubMedGoogle Scholar
• Hillas G, Perlikos F, Tsiligianni I, Tzanakis N. Managing comorbidities in COPD. Int J Chron Pulmon Dis. 2015;10:95–109. doi:10.2147/COPD.s54473.
   PubMed Web of Science ®Google Scholar
• Jorgensen NR, Schwarz P, Holme I, Henriksen BM, Petersen LJ, Backer V. The prevalence of osteoporosis in patients with chronic obstructive pulmonary disease: a cross sectional study. Respir Med. 2007;101:177–185. doi:10.1016/j.med.2006.03.029.
   PubMed Web of Science ®Google Scholar
• Fabbri LM, Rabe KF. From COPD to chronic systemic inflammatory syndrome? Lancet 2007;370(9589):797–799. doi:10.1016/S0140-6776(07)61383-X.
   PubMed Web of Science ®Google Scholar
• Westerik JAM, Metting EI, van Boven JFM, Tiersma W, Kocks JWH, Schermer TR. Association between chronic comorbidity and exacerbation risk in primary care patients with COPD. Respir Res. 2017;18(31):1–17. doi:10.1186/s12931-017-0412-2.
   PubMedGoogle Scholar
• PremierConnect Research [Internet]. 2018. [cited 2018 May 10]. Available from: https://www.premierinc.com/transforming-healthcare/healthcareperformance improvement/premier-applied-sciences/premierconnect-research/.
   Google Scholar
• Collison KA, Patel P, Preece AF, Stanford RH, Sharma RK, Feldman G. A randomized clinical trial comparing the ELLIPTA and handihaler dry powder inhalers in patients with COPD: inhaler-specific attributes and overall patient preference. COPD 2018;15(1):46–50. doi:10.1080/15412555.2017.1400000.
   PubMedGoogle Scholar
• Mannino DM, Higuchi K, Yu TC, Zhou H, Li Y, Tian H, Suh K. Economic burden of COPD in the presence of comorbidities. Chest 2015;148(1):138–150. doi:10.1378/chest.14-2434.
   PubMed Web of Science ®Google Scholar
• Schnell K, Weiss CO, Lee T, Krishnan JA, Leff B, Wolff JL, Boyd C. The prevalence of conditions in patients with physician-diagnosed COPD: a cross-sectional study using data from NHANES 1999-2008. BMC Pulm Med. 2012;12(26):1–9. Available from: http://www.biomedcentral.com/1471-2466/12/26.
   PubMedGoogle Scholar
• Madani Y, Saigal A, Sunny J, Morris L, Johns RH. Characterization of chronic obstructive pulmonary disease patients with a long length of stay: a retrospective observational cohort study. Turk Thorac J. 2017;18:119–124. doi:10.5152/Turk.
   PubMed Web of Science ®Google Scholar
• Elixhauser A, Steiner C, Harris RD, Coffey CM. Comorbidity measures for use with administrative data. Med Care. 1998;36(1):8–27. Available from: https://insights.ovid.com/pubmed?pmid = 9431328.
   PubMed Web of Science ®Google Scholar
• Kinnunen T, Saynajakangas O, Tuuponen T, Keistinen T. Impact of comorbidities on the duration of COPD patients’ hospital episodes. Respir Med. 2003;97:143–146. Available from: http://www.sciencedirect.com.
   PubMed Web of Science ®Google Scholar
• Aryal S, Diaz-Guzman E, Mannino DM. Epidemiology of comorbidities in chronic obstructive pulmonary disease: clusters, phenotypes and outcomes. Ital J Med. 2012;6:276–284. doi:10.1016/j.itjm.2012.02.006.
   Google Scholar
• Wang Y, Stavem K, Dahl FA, Humerfelt S, Haugen T. Factors associated with a prolonged length of stay after acute exacerbation of chronic obstructive pulmonary disease (AECOPD). Int J Chron Obstruct Pulmon Dis. 2014;9:99–105. doi:10.2147/COPD.S51467.
   PubMed Web of Science ®Google Scholar
• Diez JDM, Morgan JC, Garcia RJ. The association between COPD and heart failure: a review. Int J Chron Obstruct Pulmon Dis. 2013;8:305–312. doi:10.2147/COPD.S31236.
   PubMed Web of Science ®Google Scholar
• Sanders-van Wijk S, van Empel V, Knackstedt C, LaRocca HPB. Heart failure and COPD: time to shift? Int J Cardiol. 2014;172(2):293–294. doi:10.1016/jijcard.2013.12.285.
   PubMed Web of Science ®Google Scholar
• Vorhies JS, Wang Y, Herndon JH, Maloney WJ, Huddleston JI. Decreased length of stay after TKA is not associated with increased readmission rates in a national medicare sample. Clin Orthop Relat Res. 2012;470:166–171. doi:10.1007/s11999-011-1957-0.
   PubMed Web of Science ®Google Scholar
• Sievi NA, Clarenbach CF, Camen G, Rossi VA, van Gestel AJR, Kohler M. High prevalence of altered cardiac repolarization in patients with COPD. BMC Pulm Med. 2014;14(55):1–8. doi:10.1186/1471-2466-14-55.
   PubMedGoogle Scholar
• Terzano C, Colamesta V, Unim B, Romani S, Meneghini A, Volpe G, La Torre G. Chronic obstructive pulmonary disease (COPD) exacerbation: impact of comorbidities on length and costs during hospitalization. Eur. Rev. Med Pharmaco Sci. 2017;21:3680–3689. Accessed from: https://www.europeanreview.org/article/13285.
   PubMed Web of Science ®Google Scholar
• Nowinski A, Kaminski D, Korzybski D, Stoktosa A, Gorecka D. The impact of comorbidities on the length of hospital treatment in patients with chronic obstructive pulmonary disease. Pneumonol Alergol Pol. 2011;79(6):388–396. Available from: https://journals.viamedica.pl/advances_in_respiratory_medicine/article/view/27622.
   PubMedGoogle Scholar
• Rycroft CE, Heyes A, Lanza L, Becker K. Epidemiology of chronic obstructive pulmonary disease: a literature review. Int J Chron Pulmon Dis. 2012;7:457–494. doi:10.2147/COPD.S32330.
   PubMed Web of Science ®Google Scholar
• Incalzi RA, Corsonello A, Pedone C, Battaglia S, Paglino G, Belli V. Chronic renal failure: a neglected comorbidity of COPD. Chest 2010;137(4):831–837. doi:10.1378/chest.09-1710.
   PubMed Web of Science ®Google Scholar
• AbdelHalim HA, AbEINaga HH. Is renal impairment an anticipated COPD morbidity. Respir Care 2016;61(9):1201–1206. doi:10.4187/respcare.04516.
   PubMed Web of Science ®Google Scholar
• Yoshizawa T, Okada K, Furuichi S, Ishiguro T, Yoshizawa A, Akahoshi T, Gon Y, Akashiba T, Hosokawa Y, Hashimoto S. Prevalence of chronic kidney diseases in patients with chronic obstructive pulmonary disease: assessment based on glomerular filtration rate estimated from creatinine and cystatin C levels. Int J Chron Obstruct Pulmon Dis. 2015;10:1283–1289. doi: 10.2147/COPD.580673.
   PubMed Web of Science ®Google Scholar
• Barakat MF, McDonald HI, Collier TJ, Smeeth L, Nitsch D, Quint JK. Acute kidney disease in stable COPD and at exacerbation. Int J Chron Obstruct Pulmon Dis. 2015;10:2067–2077. doi:10.2147/COPD.588759.
   PubMed Web of Science ®Google Scholar
• Itoh M, Tsuji T, Nemoto K, Nakamura H, Aoshiba K. Undernutrition in patients with COPD and its treatment. Nutrients 2013;5:1316–1335. doi:10.3390/nu5041316.
   PubMed Web of Science ®Google Scholar
• Akinyemiju T, Meng Q, Vin-Raviv N. Association between body mass index and in-hospital outcomes: analysis of the nationwide inpatient database. Medicine 2016;95(28):1–8. doi:10.1097/MD.0000000000004189.
   Web of Science ®Google Scholar
• Zhang MWB, Roger CM, Cheung MWL, Fu E, Mak A. Prevalence of depressive symptoms in patients with chronic obstructive pulmonary disease: a systematic review, meta-analysis and meta-regression. Gen Hosp Psychiatry 2011;33(3):217–223. doi: 10.1016/j.genhosppsych.2011.03.009.
   PubMed Web of Science ®Google Scholar
• Norwood R. Prevalence and impact of depression in chronic obstructive pulmonary disease patients. Curr Opin Pulm Med. 2006;12(2):113–117. doi:10.1097/01.mcp.00002086.50231.c6.
   PubMed Web of Science ®Google Scholar
• Martinez CH, Mannino DM, Curtis JL, Han MK, Diaz AA. Socioeconomic characteristics are major contributors to ethnic differences in health status in obstructive lung disease: an analysis of the national health and nutrition examination survey 2007-2010. Chest 2015;148(1):151–158. doi:10.1378/chest.14-1814.
   PubMed Web of Science ®Google Scholar
• Rogliani P, Calzetta L, Segreti A, Barrile A, Cazzola M. Diabetes mellitus among outpatients with COPD attending a university hospital. Acta Diabetol. 2014;51(6):933. doi:10.1007/s00592-014-0584-0.
   PubMed Web of Science ®Google Scholar
• Cazzola M, Rogliani P, Calzetta L, Lauro D, Page C, Matera MG. Targeting mechanisms linking COPD to type 2 diabetes mellitus. Trends Pharmacol Sci. 2017;38(10):940–951. doi:10.1016/j.tips.2017.07.003.
   PubMed Web of Science ®Google Scholar
• Mannino DM, Thorn D, Swenson A, Holguin F. Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD. Eur Respir J. 2008;32:962–969. doi:10.1183/09031936.00012408.
   PubMed Web of Science ®Google Scholar
• Mapel D. Renal and hepatobiliary dysfunction in chronic obstructive pulmonary disease. Curr Opin Pulm Med. 2014;20(2):186–193. doi:10.1097/MCP.0000000000000024.
   PubMed Web of Science ®Google Scholar
• Eisner MD, Blanc PD, Omachi TA, Yelin EH, Sidney S, Katz PP, Ackerson LM, Sanchez G, Tolstykh I, Iribarren C. Socioeconomic status. race, and COPD health outcomes. J Epidemiol Community Health 2011;65(1):26–34. doi:10.1136/jech.2009.089722.
   PubMed Web of Science ®Google Scholar
• McCullough AR, Ryan C, Macindoe C, Yii N, Bradley JM, O’Neill B, Elborn JS, Hughes CM. Behavior change theory, content and delivery of interventions to enhance adherence in chronic respiratory disease: a systematic review. Respir Med. 2016;116:78–84. doi:10.1016/j.rmed.0016.05.021.
   PubMed Web of Science ®Google Scholar